IART - Integra LifeSciences Holdings Corp Stock Price, Fair Value and News

$21.80+0.09 (+0.41%)

Market Closed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

IART Price Action

Last 7 days

-9.3%

Last 30 days

-4.9%

Last 90 days

25.3%

Trailing 12 Months

-50.9%

IART RSI Chart

IART Valuation

Market Cap

1.7B

Price/Earnings (Trailing)

-257.05

Price/Sales (Trailing)

1.07

EV/EBITDA

-123.08

Price/Free Cashflow

44.22

IART Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

IART Fundamentals

IART Revenue

Revenue (TTM)

1.6B

Rev. Growth (Yr)

-0.41%

Rev. Growth (Qtr)

-8.93%

IART Earnings

Earnings (TTM)

-6.5M

Earnings Growth (Yr)

-154.85%

Earnings Growth (Qtr)

13.76%

IART Profitability

EBT Margin

-0.76%

Return on Equity

-0.43%

Return on Assets

-0.16%

Free Cashflow Yield

2.26%

IART Investor Care

Buy Backs (1Y)

1.29%

Diluted EPS (TTM)

-0.08

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	1.5B	1.6B	1.6B	0
2023	1.6B	1.5B	1.5B	1.5B
2022	1.6B	1.6B	1.6B	1.6B
2021	1.4B	1.5B	1.5B	1.5B
2020	1.5B	1.4B	1.4B	1.4B
2019	1.5B	1.5B	1.5B	1.5B
2018	1.3B	1.4B	1.5B	1.5B
2017	1.0B	1.0B	1.1B	1.2B
2016	917.0M	953.6M	977.6M	992.1M
2015	816.2M	831.8M	860.6M	882.7M
2014	822.6M	814.1M	798.4M	796.7M
2013	831.3M	826.7M	829.9M	836.2M
2012	795.2M	812.1M	820.0M	830.9M
2011	740.4M	755.1M	770.7M	780.1M
2010	694.2M	707.1M	721.5M	732.1M
2009	0	0	0	682.5M

Get all data in R, Python etc through our Historical Stock Data APIs

About Integra LifeSciences Holdings Corp

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia repair, peripheral nerve repair and protection, and tendon repair. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.

CEO	Mr. Jan De Witte
WEBSITE	integralife.com
SECTOR	Healthcare
INDUSTRY	Medical Devices
EMPLOYEES	3722

Integra LifeSciences Holdings Corp Frequently Asked Questions

What is the ticker symbol for Integra LifeSciences Holdings Corp? What does IART stand for in stocks?

IART is the stock ticker symbol of Integra LifeSciences Holdings Corp. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Integra LifeSciences Holdings Corp (IART)?

As of Fri Dec 20 2024, market cap of Integra LifeSciences Holdings Corp is 1.68 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of IART stock?

You can check IART's fair value in chart for subscribers.

Is Integra LifeSciences Holdings Corp a good stock to buy?

The fair value guage provides a quick view whether IART is over valued or under valued. Whether Integra LifeSciences Holdings Corp is cheap or expensive depends on the assumptions which impact Integra LifeSciences Holdings Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for IART.

What is Integra LifeSciences Holdings Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Dec 20 2024, IART's PE ratio (Price to Earnings) is -257.05 and Price to Sales (PS) ratio is 1.07. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. IART PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Integra LifeSciences Holdings Corp's stock?

In the past 10 years, Integra LifeSciences Holdings Corp has provided -0.02 (multiply by 100 for percentage) rate of return.